Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nicotinic acetylcholine receptor alpha4 subunit (nAChRα4) is a protein encoded by the CHRNA4 gene in humans. It is a critical subunit of nicotinic acetylcholine receptors (nAChRs), which are ligand-gated ion channels that mediate fast signal transmission at synapses. The most common configuration in the brain consists of two alpha4 (α4) subunits and three beta2 (β2) subunits, forming the α4β2 receptor, which exists in two distinct stoichiometries with varying nicotine sensitivities and calcium permeabilities. The alpha4 subunit can also combine with beta4 subunits. Upon binding to acetylcholine or nicotine, the receptor undergoes a conformational change, opening an ion-conducting channel across the plasma membrane, allowing ions like calcium, sodium, and potassium to cross the cell membrane. Alpha4-containing nAChRs play a crucial role in nicotine addiction, learning, attention, and growth hormone secretion. They are implicated in epilepsy, movement disorders, and cardiovascular conditions, making them therapeutic targets for smoking cessation, cognitive disorders, epilepsy, and movement disorders.
Agonist binding leading to ion channel opening and ion flux across the cell membrane.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nicotinic Acetylcholine Receptor Alpha4 Subunit (nAChRα4).